Graf Akcie AMPH (Amphastar Pharmaceuticals Inc). Diskuze k akciím AMPH. Aktuální informace AMPH.

Základní informace o společnosti Amphastar Pharmaceuticals Inc (Akcie AMPH)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 916.03M
Hodnota podniku (EV) 807.54M
Tržby 384.035M
EBITDA 54.393M
Zisk 10.454M
Růst v tržbách Q/Q 18.48 %
Růst v tržbách Y/Y 14.98 %
P/E (Cena vůči ziskům) 86.86
Forward P/E 0.20
EV/Sales 2.10
EV/EBITDA 14.85
EV/EBIT 42.52
PEG 1.01
Price/Sales 2.39
P/FCF 17.49
Price/Book 2.28
Účetní hodnota na akcii 8.39
Hotovost na akcii 2.29
FCF vůči ceně 5.72 %
Počet zaměstnanců 1,980
Tržba na zaměstnance 193.957k
Profit margin 0.40 %
Operating margin 7.10 %
Gross margin 40.97 %
EBIT margin 4.95 %
EBITDA margin 14.16 %
EPS - Zisk na akcii 0.22
EPS - Kvartální růst 31.25 %
EPS - Očekávaný růst příští rok 60.00 %
Return on assets 1.64 %
Return on equity 2.56 %
ROIC 0.95 %
ROCE 3.51 %
Dluhy/Equity 0.45
Čistý dluh/EBITDA -3.75
Current ratio 2.50
Quick Ratio 1.71
Volatilita 2.38
Beta 0.58
RSI 50.69
Cílová cena analytiků 22
Známka akcie (dle analytiků) 2.14
Insider ownership 23.61 %
Institutional ownership 55.96 %
Počet akcií 48.032M
Procento shortovaných akcií 6.73 %
Short ratio 15.65 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2014
Země United States

Finanční výsledky akcie AMPH

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$322.357$294.666$240.175$255.165$251.519$210.461
Cost Of Goods Sold$190.434$187.681$149.666$150.969$174.172$159.205
Gross Profit$131.923$106.985$90.509$104.196$77.347$51.256
Research And Development Expenses$68.853$57.564$43.503$41.522$37.271$28.866
SG&A Expenses$63.109$58.044$50.918$47.298$46.974$40.373
Other Operating Income Or Expenses--$2.643---
Operating Expenses$322.396$303.289$241.444$239.789$258.417$228.444
Operating Income$-0.039$-8.623$-1.269$15.376$-6.898$-17.983
Total Non-Operating Income/Expense$60.267$-1.303$2.518$-0.746$-3.466$-0.165
Pre-Tax Income$60.228$-9.926$1.249$14.63$-10.364$-18.148
Income Taxes$13.723$-3.266$-2.398$4.81$-7.577$-7.449
Income After Taxes$46.505$-6.66$3.647$9.82$-2.787$-10.699
Other Income------
Income From Continuous Operations$46.505$-6.66$3.647$9.82$-2.787$-10.699
Income From Discontinued Operations------
Net Income$48.939$-5.738$3.647$9.82$-2.787$-10.699
EBITDA$18.071$7.893$14.541$30.054$6.354$-3.535
EBIT$-0.039$-8.623$-1.269$15.376$-6.898$-17.983
Basic Shares Outstanding474646454542
Shares Outstanding504648484542
Basic EPS$1.04$-0.12$0.08$0.22$-0.06$-0.25
EPS - Earnings Per Share$0.98$-0.12$0.08$0.21$-0.06$-0.25
# 2020 2019 2018 2017 2016 2015
Current Ratio2.83572.06252.79463.0372.93443.1631
Long-term Debt / Capital0.08440.08070.1090.08950.09260.1136
Debt/Equity Ratio0.11030.13780.14130.11460.13910.155
Gross Margin40.924536.307237.684640.834830.75224.3542
Operating Margin-0.0121-2.9264-0.52846.0259-2.7425-8.5446
EBIT Margin-0.0121-2.9264-0.52846.0259-2.7425-8.5446
EBITDA Margin5.60592.67866.054311.77832.5263-1.6796
Pre-Tax Profit Margin18.6836-3.36860.525.7335-4.1206-8.623
Net Profit Margin15.1816-1.94731.51853.8485-1.1081-5.0836
Asset Turnover0.54920.57380.53250.59650.64470.5405
Inventory Turnover Ratio1.72342.70742.35291.89292.46481.9337
Receiveable Turnover7.05585.64365.71419.52147.51459.101
Days Sales In Receivables51.730764.674563.877138.334648.572540.1054
ROE - Return On Equity10.8777-1.82791.09282.9825-0.9431-3.7959
Return On Tangible Equity12.0362-2.06771.26373.5204-1.0903-4.4711
ROA - Return On Assets7.9229-1.29680.80852.2958-0.7144-2.7478
ROI - Return On Investment9.9599-1.68040.97362.7156-0.8558-3.3648
Book Value Per Share9.1797.81377.1587.11926.53816.3131
Operating Cash Flow Per Share0.01360.0125-0.0010.5741-0.2642-0.2965
Free Cash Flow Per Share0.1846-0.2655-0.27660.4798-0.1314-0.3144